Daxinganling Lingebei Cold Zone Biotechnology Co., Ltd. is located in Xiaoyangqi Town, Songling District. It is a national-level high-tech enterprise focusing on extracting plants from cold zone forests, producing biological health products and high-end biopharmaceuticals. The company was established in 2002 with a registered capital of 120 million yuan, total assets of 350 million yuan, and more than 300 employees. The company has 4 wholly-owned subsidiaries, 2 holding subsidiaries, and 1 provincial-level frigid zone plant bioengineering technology center. Has two major production bases: Songling District production base, Qiqihar City Dinghengsheng Pharmaceutical production base. There are a total of 10 production workshops, covering the production and sales of food, health products, medicines, and Chinese herbal decoction pieces. Among them, the Songling District workshop covers an area of more than 100,000 square meters, with a construction area of more than 30,000 square meters. Currently, there are 6 plants and Chinese medicine extraction workshops and 1 health food and food workshop.

The company has been awarded "National High-tech Enterprise", "Heilongjiang High-tech Enterprise", "Heilongjiang Province Patent Advantage Cultivation Enterprise", "Innovative Outstanding Technology Enterprise in Daxinganling Area" and many other honors and awards title. The products have obtained EU organic certification, HALAL certification, quality management system certification, Chinese medicine GMP certification and HACCP certification. The company's engineering technology center, R&D center, and quality inspection center have more than 50 sets of gas chromatography, liquid chromatography, ultraviolet spectrophotometer and other instruments and equipment, and complete R&D, inspection and testing equipment and facilities.

So far, 113 national intellectual property patents have been declared, 61 national invention patents with independent intellectual property rights authorized, and 15 registered trademarks. The company has always insisted on continuous innovation and research. In 2019, it applied for 6 national invention patents and applied for two forestry industry standards in 2020.

After more than 10 years of innovation and research and development, the company has formed an industrial layout for the coordinated development of three major sectors.

1. The big health and natural plant extracts section: the company uses the natural pollution-free resource treasure house of Daxinganling to produce more than 300 kinds of natural plant extracts, health foods, and functional foods, mainly including blueberry anthocyanin series and nettle extract , Birch Phellinus igniarius extract, Silymarin and Propolis Ganoderma lucidum capsules, Ringer Bell Ringer Bell Capsules, Blueberry Lutein Soft Capsules, Anthocyanin tablets, etc.

2. Dinghengsheng Pharmaceuticals: Heilongjiang Dinghengsheng Pharmaceutical Co., Ltd. was acquired in 2016. Heilongjiang Dinghengsheng Pharmaceutical Co., Ltd. was founded in 1644 AD. It is the earliest established traditional Chinese medicine company in Heilongjiang Province and has experienced more than 300 years. At present, it has developed into a modern pharmaceutical enterprise integrating R&D, production and sales. It has five drug production lines that have passed GMP certification, producing three dosage forms of tablets, capsules and granules, a total of 143 varieties of national medicine quasi-word drugs and 11 varieties of external drugs. He has successively won many honors such as "Crane City Time-honored Brand", "Longjiang Time-honored Brand" and "China Time-honored Brand".

3. Industrial hemp segment: Industrial hemp refers to the original plant of the genus Cannabis and its extracted products with a THC content of less than 0.3% (weight percentage of dry matter). Our company began to plant industrial hemp in 2019, and the planting area has increased to 50,000 mu in 2020, and 5 related processing patents have been applied for at home and abroad. A multi-variety diversified production capacity has been formed for industrial hemp planting, industrial hemp flower and leaf extraction and processing, hemp protein processing, and hemp oil processing.

In the next step, the company will mainly use Ringelberg as the main body of the group, mainly positioning project incubation and research and development. The three sectors are independently operated and developed in a coordinated manner, and the big health and plant extract sectors are operated by the group as the main body.

Dinghengsheng Pharmaceutical Co., Ltd. cooperated with Shandong Hayi Chinese Medicinal Materials Co., Ltd. to introduce its mature management team and market for operation and management, forming a growth rate of more than 30% per year within three years, and independently listing Dinghengsheng Pharmaceutical. The NEEQ counseling contract has been signed, and the relevant listing materials will be submitted in January 2021. The NEEQ listing will be transferred to the GEM in 2022.

At the same time, Lingebei Pharmaceutical was established in Songling District of Daxing'anling to take advantage of the extraction advantages and transfer some Chinese medicine varieties to Lingebei Pharmaceutical. It produces three dosage forms of tablets, capsules and granules, and will be independent on the Science and Technology Innovation Board within three years. Listed. Formed a situation where two pharmaceutical companies, Dinghengsheng and Lingebei, echoed each other.

The industrial hemp sector established Heilongjiang Nabes Biotechnology Co., Ltd. to operate the sector, introduced advanced capital management teams from Shanghai and other places to invest in shares, and made good use of relevant policies that were successively introduced to seize the international market in a timely manner.

Faced with the alternation of the old and new patterns of the Chinese herbal medicine industry in China, the survival of the fittest in the industry has intensified, and the traditional market and operators are facing increasingly difficult conditions, the company has been planning to upgrade the technology of the production of Chinese herbal medicine pieces and extracts, workshop construction, Transform, improve the overall R&D and production level of the enterprise, accelerate the construction of the entire industrial chain of Chinese herbal medicine, and make the production and processing of Chinese medicine in our region move towards sustainable modernization.

During the 14th Five-Year Plan period, the Group strives to ensure the listing and development of two pharmaceutical companies. In order to support the industrial layout of the three sectors, the Group will focus on the promotion of Chinese medicinal materials and industrial hemp planting projects in the Greater Xing'an Mountains area to form its own planting base for authentic medicinal materials.